Phase II randomised, placebo-controlled, clinical trial of interleukin-1 receptor antagonist in intracerebral haemorrhage: BLOcking the Cytokine IL-1 in ICH (BLOC-ICH).
- Resource Type
- Article
- Source
- European Stroke Journal; Sep2023, Vol. 8 Issue 3, p819-827, 9p
- Subject
- Language
- ISSN
- 23969873